HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment

Designation recognizes the potential of HeartBeam’s 3D ECG technology to help physicians assess suspected heart attacks outside the hospitalBreakthrough status provides prioritized FDA interaction as HeartBeam advances